Search

05/04 (1) Trump's Warp-Speed Plan aims to produce COVID-19 vaccinethis year. COVID-19 Addenda: 1) CDC reports latest coronavirus cases,deaths; 2) Amgen lobs Otezla into COVID-19 derby; 3)COVID-19 pandemic likely to last two years, report says; and 4)Arthritis drug didn't help seriously ill COVID patients. The company hasbeen in talks with the FDA about how the drug will be used, and said itexpects the antiviral medication to be a backbone of therapy as well asproof that other drugs can target the virus. Six critically ill COVID-19patients were treated with CAP-1002, a new cell therapy currently beingdeveloped for the treatment of Duchenne muscular dystrophy (DMD). [Extracted from the article]

Piedmont Healthcare is participating in a large international clinical trial to study the effects of ventilation and Extracorporeal Membrane Oxygenation, or ECMO, in the critical care setting on patients suffering [...]

After lifting herself up, she poked fund at the motivational industry while promoting her own brand of self-fulfillment in workshops and popular books. Positive affirmations gave her a headache. She [...]

Not having an accurate, honest, nationwide way to tally Covid-19 cases will only add to the current tragedy. We recently received the death certificate for my mother, who died May [...]

May 10-- May 10--Pluristem Therapeutics Inc. (Nasdaq:PSTI; TASE: PSTI: PSTI) Therapeutics Inc. (PSTI) (PSTI) announced on Thursday that the US Food and Drug Administration (FDA) had cleared the company's Investigational [...]

Byline: Kevin Leininger April 09-- Apr. 9--About 375,000 Americans have contracted COVID-19, according to the Centers for Disease Control, and between 10 percent and 25 percent of them eventually will [...]

Internationally recognized in pulmonology, he helped define acute respiratory distress syndrome, a condition that led to his death, attributed to the coronavirus. This obituary is part of a series about [...]

Byline: Jamie Martines March 25-- Mar. 25--Allegheny County reported 88 active coronavirus cases Wednesday, up from 58 on Tuesday, marking the biggest single-day increase since the county first began reporting [...]

March 24-- Mar. 24--A seventh person has died from the coronavirus in Virginia. A Virginia Beach man in his 70s died Monday from acute respiratory failure after testing positive for [...]

Byline: Philip Kennicott In 2008, a California nonprofit organization ran a multiplayer online game they titled 'Superstruct.' Among the scenarios the Palo Alto-based Institute for the Future considered in its [...]

Byline: Stacey Burling When she was 33, Eileen Rubin learned firsthand what it's like to have acute respiratory distress syndrome or ARDS, a life-threatening condition she had never heard of. [...]

Three more persons (PH6, PH5, and PH37) infected with Coronavirus 2019 (COVID-19) died on Thursday, the Department of Health (DOH) said. The DOH said that the latest deaths recorded brings [...]

Byline: Marian Accardi March 07-- Mar. 7--ATHENS -- The judge handling Limestone County Sheriff Mike Blakely's felony trial chastised his lawyer today for falsely claiming the hospitalized sheriff was being [...]

COPD is a chronic lung disease that makes it difficult to breathe. COPD is the third leading cause of death in the US, with more than 15 million people currently [...]

Byline: Ross Lydall Health Editor DOCTORS are turning to artificial intelligence in a bid to boost survival rates for the sickest NHS patients. Researchers at Imperial College London are to [...]

Biopharmaceutical company RedHill Biopharma has announced that the preliminary results from a preclinical study with a new oral drug, opaganib, showed a reduction of thrombosis (blood clotting) in an acute [...]

Menlo Park, California: CohBar, Inc. has issued the following press release: CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend [...]

PALM BEACH: FinancialNewsMedia.com has issued the following news release: All around the globe, scientists are working hard to develop effective treatments, therapies and vaccines to halt the COVID-19 pandemic. Therapies [...]

NEW YORK: CorVent Medical, Inc. has issued the following press release: CorVent Medical, a Coridea portfolio company focused on developing versatile, reusable, lifesaving ventilators, announced today that the U.S. Food [...]

CorVent Medical, a Coridea portfolio company focused on developing versatile, reusable, lifesaving ventilators, announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) [...]

Pharmaceutical manufacturer Zydus Cadila said it received permission to initiate clinical trials for ZYIL1, an oral small molecule NLRP3 inhibitor, as an anti-inflammatory agent. The molecule is being explored for [...]

CHEYENNE: EV Biologics Corporation has issued the following news release: EV Biologics Corp (OTC PINK:YECO) today announced that it has signed a funding agreement with an investment bank to sponsor [...]

Novartis has signed an exclusive US$50?million worldwide licence and collaboration agreement with Australian regenerative medicinecompany Mesoblast. The agreement would allow Novartis to develop, manufacture and commercialise Mesoblastsmesenchymal stromal cell (MSC) [...]

Sydney, Australia: Mesoblast limited has issued the following news release: Worldwide license and collaboration agreement with Novartis for the development, manufacture and commercialization of remestemcel-L [?] Initial focus is on [...]

Vancouver: PreveCeutical Medical Inc. has issued the following news release: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ('PreveCeutical'), is pleased to announce the successful laboratory development of a [...]

MISSOURI CITY: Arcos Inc. has issued the following news release: Arcos, Inc. announced today it would provide six months' free use of Vent Navigator, a new Clinical Decision Support (CDS) [...]

London: Hogan Lovells has issued the following press release: Global law firm Hogan Lovells has advised international pharmaceutical company Novartis in connection with an exclusive worldwide license and collaboration agreement [...]

London: Evgen Pharma PLC has issued the following press release: Evgen Pharma PLC - clinical stage drug development company based in Liverpool - First patient enrolled in dosed in phase [...]

The Icahn School of Medicine at Mount Sinai, Department of Medicines Clinical Trials Office and Boehringer Ingelheim have enrolled the first patient to evaluate nintedanib in adult patients with acute [...]

Novartis inked an exclusive worldwide license and collaboration deal with Australia-based Mesoblast to develop, commercialize and manufacture remestemcel-L for acute respiratory distress syndrome (ARDS), including when it is linked to [...]

Swiss pharma Novartis has inked an exclusive licence and collaboration agreement with Mesoblast to develop remestemcel-L for acute respiratory distress syndrome (ARDS), including COVID-19-associated ARDS. Currently, remestemcel-L is being studied [...]

(GlobeNewswire) - Mesoblast Limited (Nasdaq:MESO; ASX:MSB), today announced that it has entered into an exclusive worldwide license and collaboration agreement with Novartis for the development, manufacture and commercialization of Mesoblasts [...]

(GlobeNewswire) - Mesoblast Limited (Nasdaq:MESO; ASX:MSB), today announced that it has entered into an exclusive worldwide license and collaboration agreement with Novartis for the development, manufacture and commercialization of Mesoblasts [...]

Israeli firm BioLineRx is set to initiate Phase Ib trial of its lead cancer therapy, Motixafortide, in patients suffering from acute respiratory distress syndrome (ARDS) secondary to Covid-19 and other [...]

Israeli clinical-stage biopharmaceutical company announced Wednesday that its lead drug candidate, the CXCR4-inhibitor Motixafortide, will be evaluated in an investigator-initiated clinical trial in patients suffering from acute respiratory distress syndrome [...]

London: Evgen Pharma PLC has issued the following press release: Evgen Pharma PLC - Phase 2/3 trial of lead asset SFX-01's potential in reducing severity or preventing the onset of [...]

The Biomedical Advanced Research and Development Authority (BARDA) will provide technical assistance on a Phase 3 clinical trial underway to evaluate the drug lenzilumab being developed by Humanigen. The drug [...]

(GlobeNewswire) - Aerpio Pharmaceuticals, Inc.('Aerpio') (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, as well as other indications in [...]

CINCINNATI, Nov 05, 2020 (GLOBE NEWSWIRE via COMTEX) -- Aerpio Pharmaceuticals, Inc.('Aerpio') (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic [...]

VIRULINA is a preclinically and clinically tested product which has been validated as an effective adjunct remedy for the prevention of ARDS caused due to COVID-19 infection Chitkara University, Chitkara [...]

(GlobeNewswire) - Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced that it has received a Study May Proceed letter [...]

ALAMEDA: AgeX Therapeutics, Inc. has issued the following news release: AgeX Therapeutics, Inc. ('AgeX': NYSE American: AGE), a biotechnology company developing innovative regenerative therapeutics to treat human diseases to increase [...]

LA JOLLA, Calif., Oct 29, 2020 (GLOBE NEWSWIRE via COMTEX) -- Equillium plans to initiate global Phase 3 COVID-19 trial - EQUINOX - during Q4 2020 FDA indicates study could [...]

The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19. Some [...]

The US National Institutes of Health (NIH) has initiated a Phase III ACTIV-1 Immune Modulators (IM) trial to assess the safety and efficacy of three immune modulator agents in hospitalised [...]

The COVID-19 pandemic is posing an unprecedented challenge to the world. Though many patients experience only mild symptoms, up to 30% of severely infected patients require admission to intensive care [...]

The National Institute of Health (NIH) is beginning its clinical trial to use immune modulators as a treatment against COVID-19. In a news release, the NIH stated that it has [...]

The National Institutes of Health (NIH) today announced the launch of a Phase III clinical trial to determine the safety and efficacy for patients hospitalized with COVID-19 of three separate [...]

BETHESDA, Md. -- The following information was released by the National Institutes of Health: The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the [...]